Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Smith & Nephew Plc
  6. Summary
    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/21/2021 07/22/2021 07/23/2021 07/26/2021 07/27/2021 Date
1544.5(c) 1547.5(c) 1554.5(c) 1519(c) 1521.5 Last
2 375 856 853 633 1 067 780 971 130 1 408 581 Volume
+3.59% +0.19% +0.45% -2.28% +0.16% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 5 371 M - -
Net income 2021 463 M - -
Net Debt 2021 1 850 M - -
P/E ratio 2021 40,5x
Yield 2021 1,76%
Sales 2022 5 700 M - -
Net income 2022 701 M - -
Net Debt 2022 1 578 M - -
P/E ratio 2022 26,4x
Yield 2022 2,01%
Capitalization 18 439 M 18 432 M -
EV / Sales 2021 3,78x
EV / Sales 2022 3,51x
Nbr of Employees 17 914
Free-Float 98,7%
More Financials
Company
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The... 
More about the company
Ratings of Smith & Nephew Plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about SMITH & NEPHEW PLC
07/22SMITH & NEPHEW : Study shows Smith+Nephew's REGENETEN Bioinductive Implant sets ..
AQ
07/21SMITH & NEPHEW : Says Regeneten Bioinductive Implant Improves Shoulder Function ..
MT
07/21SMITH & NEPHEW : Study shows Smith+Nephew's REGENETEN◊ Bioinductive Implant ..
PU
07/21Smith+Nephew Announces Study Results Showing Patients Treated with Just its R..
CI
07/19SMITH & NEPHEW : Commission pursuant to Rule 12g3-2 (b) under the Securities Exc..
PU
07/14SMITH & NEPHEW : +Nephew launches Real Intelligence and CORI? Surgical System, n..
AQ
07/08SMITH & NEPHEW : +Nephew launches the FAST-FIX◊ FLEX Meniscal Repair System;..
PU
07/08SMITH & NEPHEW : +Nephew launches the FAST-FIX? FLEX Meniscal Repair System; ext..
AQ
07/08SMITH & NEPHEW : Timing of Smith+Nephew Second Quarter Trading and First Half 20..
AQ
07/07Smith+Nephew Launches the FAST-FIX FLEX Meniscal Repair System
CI
07/01SMITH & NEPHEW : Barclays Lifts Smith & Nephew PT, Keeps Overweight Rating
MT
07/01SMITH & NEPHEW : Commission pursuant to Rule 12g3-2 (b) under the Securities Exc..
PU
06/30SMITH & NEPHEW PLC : Monthly statement on outstanding equity shares and voting r..
CO
06/23Today on Wall Street: We shall not be ruled by inflation fears
06/23ANALYST RECOMMENDATIONS : Bank of America, Burberry, Glencore, Microsoft, SharpS..
More news
News in other languages on SMITH & NEPHEW PLC
06/23AVIS D'ANALYSTES DU JOUR : Kering, Hermès, Vallourec, Orsted, Ceconomy, Swatch, ..
06/09SMITH & NEPHEW : Credit Suisse relève son opinion
04/15STOCK MARKET PARIS : Des entreprises gonflées à bloc
04/15AVIS D'ANALYSTES DU JOURá : EDF, LVMH, Accor, Eurofins, Virbac, Shop Apotheke, J..
02/11ROLAND DIGGELMANN : Sonova gibt neuen CFO und Veränderungen im Verwaltungsrat be..
More news
Analyst Recommendations on SMITH & NEPHEW PLC
More recommendations
Chart SMITH & NEPHEW PLC
Duration : Period :
Smith & Nephew Plc Technical Analysis Chart | SN. | GB0009223206 | MarketScreener
Technical analysis trends SMITH & NEPHEW PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 21,00 $
Average target price 23,64 $
Spread / Average Target 12,6%
EPS Revisions
Managers and Directors
Roland D. Diggelmann Chief Executive Officer & Non-Executive Director
Anne-Francoise Nesmes Chief Financial Officer & Executive Director
Roberto Quarta Chairman
Vasant Padmanabhan President-Research & Development
Mark Gladwell President-Global Operations & Business Services
Sector and Competitors